BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23292297)

  • 1. Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
    Castel-Lacanal E; Gamé X; De Boissezon X; Guillotreau J; Braley-Berthoumieux E; Terracol C; Gasq D; Labrunee M; Viala F; Rischmann P; Clanet M; Marque P
    World J Urol; 2013 Dec; 31(6):1445-50. PubMed ID: 23292297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Tornic J; Sartori AM; Gajewski JB; Cox A; Schneider MP; Youssef NA; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2018 Nov; 37(8):2315-2322. PubMed ID: 29917273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The urinary-specific quality of life of multiple sclerosis patients: Dutch translation and validation of the SF-Qualiveen.
    Reuvers SHM; Korfage IJ; Scheepe JR; Blok BFM
    Neurourol Urodyn; 2017 Aug; 36(6):1629-1635. PubMed ID: 27794179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Intermittent Self-Catheterization Procedures in Patients with Neurogenic Lower Urinary Tract Dysfunction: Dutch Translation and Validation of the Intermittent Catheterization Satisfaction Questionnaire, Intermittent Catheterization Acceptance Test, Intermittent Self Catheterization Questionnaire and Intermittent Catheterization Difficulty Questionnaire.
    Hervé F; Ragolle I; Amarenco G; Viaene A; Guinet-Lacoste A; Bonniaud V; Everaert K
    Urol Int; 2019; 102(4):476-481. PubMed ID: 30999304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Reported Bladder Related Symptoms and Quality of Life after Spinal Cord Injury with Different Bladder Management Strategies.
    Myers JB; Lenherr SM; Stoffel JT; Elliott SP; Presson AP; Zhang C; Rosenbluth J; Jha A; Patel DP; Welk B;
    J Urol; 2019 Sep; 202(3):574-584. PubMed ID: 30958741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.
    Tubaro A; Puccini F; De Nunzio C; Digesu GA; Elneil S; Gobbi C; Khullar V
    Curr Urol Rep; 2012 Oct; 13(5):335-42. PubMed ID: 22886612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between fatigue and urinary quality of life in patients with Multiple Sclerosis.
    Giannopapas V; Kitsos DK; Panopoulou A; Mitsi Z; Stavrogianni K; Chasiotis AK; Gkika MK; Salakou S; Tsivgoulis G; Bakalidou D; Giannopoulos S
    J Clin Neurosci; 2024 Feb; 120():87-91. PubMed ID: 38237491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent clean self-catheterization in clients with neurogenic bladder resulting from multiple sclerosis.
    Henderson JS
    J Neurosci Nurs; 1989 Jun; 21(3):160-4. PubMed ID: 2525155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clean intermittent catheterization on quality of life of patients with neurogenic lower urinary tract dysfunction due to radical hysterectomy: A cross-sectional study.
    Sekido N; Takaoka EI; Nishiyama H; Ochi H; Satoh T
    Low Urin Tract Symptoms; 2021 Jan; 13(1):168-176. PubMed ID: 32929880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder-emptying methods, neurogenic lower urinary tract dysfunction and impact on quality of life in people with long-term spinal cord injury.
    Adriaansen JJ; van Asbeck FW; Tepper M; Faber WX; Visser-Meily JM; de Kort LM; Post MW
    J Spinal Cord Med; 2017 Jan; 40(1):43-53. PubMed ID: 26446581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
    Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
    BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
    Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
    Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
    Brucker BM; Nitti VW; Kalra S; Herbert J; Sadiq A; Utomo P; Aponte MM
    Neurourol Urodyn; 2017 Apr; 36(4):1208-1213. PubMed ID: 27548624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction.
    Andretta E; Simeone C; Ostardo E; Pastorello M; Zuliani C
    J Neurol Sci; 2014 Dec; 347(1-2):257-61. PubMed ID: 25454644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurogenic Lower Urinary Tract Dysfunction in Adults with Cerebral Palsy: Outcomes following a Conservative Management Approach.
    Goldfarb RA; Pisansky A; Fleck J; Hoversten P; Cotter KJ; Katorski J; Liberman D; Elliott SP
    J Urol; 2016 Apr; 195(4 Pt 1):1009-13. PubMed ID: 26498055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation and cultural adaptation of SF Qualiveen questionnaire in Greek.
    Konstantinidis C; Tzitzika M; Daoultzis KC; Samarinas M; Giannitsas K; Athanasopoulos A
    Eur J Phys Rehabil Med; 2021 Aug; 57(4):639-644. PubMed ID: 33179476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation, Cultural Adaptation and Validation of the Qualiveen-30 Questionnaire in Persian for Patients with Spinal Cord Injury and Multiple Sclerosis.
    Nikfallah A; Rezaali S; Mohammadi N; Abrishamkar M; Rezaei E; Sahraian MA; Pakpour AH; Yekaninejad MS
    Low Urin Tract Symptoms; 2015 Jan; 7(1):42-9. PubMed ID: 26663651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of bladder problems in patients with multiple sclerosis.
    Unsworth J; Freeman L
    Br J Community Nurs; 2000 May; 5(5):230, 232, 234, 236-8. PubMed ID: 12271205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualiveen, a urinary-disorder specific instrument: 0.5 corresponds to the minimal important difference.
    Bonniaud V; Bryant D; Parratte B; Guyatt G
    J Clin Epidemiol; 2008 May; 61(5):505-10. PubMed ID: 18394545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen.
    Bonniaud V; Bryant D; Parratte B; Guyatt G
    J Urol; 2008 Dec; 180(6):2592-8. PubMed ID: 18950816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.